Literature DB >> 12893467

No association between D3 dopamine receptor (DRD3) alleles and cocaine dependence.

M Freimer1, H Kranzler, S Satel, J Lacobelle, K Skipsey, D Charney, J Gelernter.   

Abstract

Cocaine is thought to act in the brain primarily by blocking dopamine re-uptake. The dopamine D3 receptor (genetic locus DRD3) is localized to brain regions that have been implicated in the reinforcing effects of a number of substances of abuse, including cocaine. The DRD3 coding region contains a polymorphism identifiable as a polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP). This polymorphism leads to an amino acid substitution at position 9 in the extracellular N-terminus of the D3 dopamine receptor. We examined alleles of the DRD3 gene in cocaine dependence using a genetic association strategy in samples of 62 white and 62 black cocaine-dependent individuals. Comparisons were made with local (Connecticut) control subjects for both groups, and with a larger sample of literature controls (for the white subjects) and a contrast group of schizophrenic patients (for the black subjects). No association was found between cocaine dependence and DRD3 alleles in either group (Bonferroni corrected). There was a significant difference in allele frequency between whites and blacks. These results are consistent with no role for genetic variation of the D3 dopamine receptor in susceptibility to cocaine dependence.

Entities:  

Year:  1996        PMID: 12893467     DOI: 10.1080/1355621961000124896

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  5 in total

1.  Association analysis between polymorphisms in the conserved dopamine neurotrophic factor (CDNF) gene and cocaine dependence.

Authors:  Falk W Lohoff; Paul J Bloch; Thomas N Ferraro; Wade H Berrettini; Helen M Pettinati; Charles A Dackis; Charles P O'Brien; Kyle M Kampman; David W Oslin
Journal:  Neurosci Lett       Date:  2009-02-21       Impact factor: 3.046

Review 2.  Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders.

Authors:  Christian A Heidbreder; Amy H Newman
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

Review 3.  Genetics of dopamine receptors and drug addiction.

Authors:  Philip Gorwood; Yann Le Strat; Nicolas Ramoz; Caroline Dubertret; Jean-Marie Moalic; Michel Simonneau
Journal:  Hum Genet       Date:  2012-02-17       Impact factor: 4.132

4.  Genetic variants in the cocaine- and amphetamine-regulated transcript gene (CARTPT) and cocaine dependence.

Authors:  Falk W Lohoff; Paul J Bloch; Andrew E Weller; Aleksandra H Nall; Glenn A Doyle; Russell J Buono; Thomas N Ferraro; Kyle M Kampman; Helen M Pettinati; Charles A Dackis; David W Oslin; Charles P O'Brien; Wade H Berrettini
Journal:  Neurosci Lett       Date:  2008-05-24       Impact factor: 3.046

Review 5.  Genetic influences on smoking: candidate genes.

Authors:  M A Rossing
Journal:  Environ Health Perspect       Date:  1998-05       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.